Fahmi, Ahmed <br/><br/>
p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.  [electronic resource] 

 -  Cellular signalling  Apr 2013 
 - 898-909 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3913 
<br/><br/><label>Standard No.: </label>10.1016/j.cellsig.2012.12.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cytokine Receptor gp130--genetics<br/>Flavonoids--pharmacology<br/>Humans<br/>Hypertrophy<br/>Imidazoles--pharmacology<br/>Interleukin-6--genetics<br/>Janus Kinases--metabolism<br/>Leukemia Inhibitory Factor--genetics<br/>Mice<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>Myocytes, Cardiac--cytology<br/>Nitric Oxide--metabolism<br/>Nitric Oxide Synthase Type II--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Pyridines--pharmacology<br/>Rats<br/>Receptors, Erythropoietin--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Recombinant Proteins--biosynthesis<br/>Reperfusion Injury--metabolism<br/>STAT1 Transcription Factor--metabolism<br/>STAT3 Transcription Factor--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism